The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), has announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) grant applications. This funding opportunity invites eligible U.S. small businesses to propose innovative projects that demonstrate significant commercialization potential, specifically excluding clinical trials. The grants aim to support research and development aligned with the missions of the NIH, CDC, and FDA, with funding amounts typically reaching up to $306,872 for Phase I and $2,045,816 for Phase II awards. Interested applicants must submit their proposals by April 5, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-24-245.html for further details.